Clinical Trial Update: Safety, Tolerability, Extended Early Bactericidal Activity and PK of Higher Doses Rifampicin in Adults With Pulmonary TB [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating safety, tolerability, extended early bactericidal activity, and pharmacokinetics of higher rifampicin doses in adults with p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis

Drugs mentioned

• Rifampicin

Snippet

Sponsor: Radboud University Medical Center | Conditions: Pulmonary Tuberculosis (TB) | Phase 2 | Status: COMPLETED